LIQUIDIA CORPORATION

LQDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $190.7M $176.5M $83.7M $93.3M $57.5M $65.3M
Accounts Receivable $54.1M $2.7M $4.1M $5.0M $3.0M
Inventory $23.8M $241.0K
Total Current Assets $273.4M $185.1M $89.9M $99.8M $61.3M $66.1M $56.4M
Property, Plant & Equipment $11.8M $8.3M $4.5M $4.2M $5.0M $6.8M $9.3M
Goodwill $3.9M $3.9M $3.9M $3.9M $3.9M $3.9M $0
Intangible Assets (Excl. Goodwill) $3.0M $3.2M $3.4M $3.7M $4.4M $5.5M $0
Total Assets $327.9M $230.3M $118.3M $129.2M $93.7M $99.5M $68.8M
Liabilities
Accounts Payable $3.7M $4.7M $1.4M $2.2M $1.1M $3.7M $3.5M
Total Current Liabilities $135.8M $41.8M $18.6M $8.8M $7.3M $11.7M $16.9M
Long-Term Debt $19.9M $10.4M $10.3M $10.3M
Total Liabilities $283.2M $150.9M $71.0M $38.8M $28.5M $28.4M $33.9M
Stockholders' Equity
Retained Earnings $-626.3M $-557.4M $-429.1M $-350.6M $-309.6M $-275.0M $-215.2M
Total Stockholders' Equity $44.7M $79.4M $47.3M $90.4M $65.3M $71.1M $34.9M